AOBIOME
LIVE

Serial Number

97353799

Owner

AOBiome LLC

Attorney

Ann Lamport Hammitte

First Use Date

Sep 12, 2024

Filing Date

Apr 8, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AOBIOME Trademark

Serial Number: 97353799 • Registration: 7732497

AOBIOME is a trademark filed by AOBiome LLC on April 8, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

AOBiome LLC (15 trademarks)

One Broadway, 14th Floor
Cambridge, MA 02142

Entity Type: 16

Trademark Details

Filing Date

April 8, 2022

Registration Date

March 18, 2025

First Use Anywhere

September 12, 2024

First Use in Commerce

September 12, 2024

Published for Opposition

March 7, 2023

Goods & Services

Medicated gels for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated creams for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated sprays for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; nasal sprays for therapeutic use; topical applications in the nature of gels, creams, sprays, and liquids for therapeutic use, namely, topical preparations containing ammonia oxidizing bacteria for the treatment of skin disorders, acne, inflammation, eye disorders, migraines, headaches, allergic reactions, insomnia, hypertension, thermoregulation, and to promote wound healing; medicated liquids for therapeutic use in the nature of therapeutic pharmaceuticals for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; biological therapeutics being pharmaceutical preparations for treatment of skin disorders, circulatory and cardiovascular disorders, neurologic diseases, inflammation, gastrointestinal disorders, respiratory disorders, eye disorders, urogenital disorders, auditory disorders, migraines, headaches, allergic rhinitis, insomnia, hyperhidrosis, acne, and hypertension; therapeutic agents for thermoregulation and promoting wound healing

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 18, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 25, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 25, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 18, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 17, 2025 AITU
USE AMENDMENT FILED
Nov 1, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 1, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 31, 2024 EXRA
SOU EXTENSION 3 GRANTED
Oct 31, 2024 EX3G
SOU EXTENSION 3 FILED
Oct 31, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 31, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 3, 2024 EXRA
SOU EXTENSION 2 GRANTED
May 2, 2024 EX2G
SOU EXTENSION 2 FILED
May 2, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
May 2, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 26, 2023 EXRA
SOU EXTENSION 1 GRANTED
Oct 24, 2023 EX1G
SOU EXTENSION 1 FILED
Oct 24, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 24, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 2, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 7, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 7, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 15, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 27, 2023 CNSA
ASSIGNED TO EXAMINER
Jan 26, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 12, 2022 NWOS
NEW APPLICATION ENTERED
Apr 12, 2022 NWAP